BPC 157 Banned: Key Facts on the Latest FDA Decision BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group FDA to weigh easing limits on unproven peptides promoted by RFK Jr. FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,